1999
Prevalence and Incidence of HIV Among Incarcerated and Reincarcerated Women in Rhode Island
Rich J, Dickinson B, Macalino G, Flanigan T, Towe C, Spaulding A, Vlahov D. Prevalence and Incidence of HIV Among Incarcerated and Reincarcerated Women in Rhode Island. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 22: 161-166. PMID: 10843530, DOI: 10.1097/00126334-199910010-00008.Peer-Reviewed Original ResearchConceptsSelf-reported injection drug useIncidence of HIVInitiation of treatmentInjection drug useCase-control studySeronegative womenRecent temporal trendsHIV testHIV infectionHIV-positiveHIV prevalenceNonwhite raceRisk factorsAnnual prevalenceMandatory HIVHigh riskControl studyDrug useSexual riskHIVWomenPrevalencePrior incarcerationIncidenceIncarcerated womenPrevalence and Incidence of HIV Among Incarcerated and Reincarcerated Women in Rhode Island
Rich J, Dickinson B, Macalino G, Flanigan T, Towe C, Spaulding A, Vlahov D. Prevalence and Incidence of HIV Among Incarcerated and Reincarcerated Women in Rhode Island. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 22: 161. DOI: 10.1097/00042560-199910010-00008.Peer-Reviewed Original ResearchSelf-reported injection drug useIncidence of HIVInitiation of treatmentInjection drug useCase-control studySeronegative womenRecent temporal trendsHIV testHIV infectionHIV-positiveHIV prevalenceNonwhite raceRisk factorsAnnual prevalenceMandatory HIVHigh riskControl studyDrug useSexual riskHIVWomenPrevalencePrior incarcerationIncidenceIncarcerated women
1997
Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study.
Rezza G, Galai N, Pezzotti P, Vlahov D, Graham N, Viale P, Angarano G. Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study. Antiviral Therapy 1997, 2: 167-74. PMID: 11322271.Peer-Reviewed Original ResearchConceptsCD4 cell countInitiation of treatmentZidovudine monotherapyP24 antigenaemiaCell countConstitutional symptomsHIV seroconvertersRisk groupsCopies/Human immunodeficiency virus seroconvertersPlasma RNA viral loadHIV RNA copiesCD4 cell declineRNA viral loadStart of therapyMarker of responseAntigen-positive individualsAdditional predictive informationIndicator of responseStandard survival methodsTerms of progressionAntiretroviral therapyViral loadAntigen levelsDisease progression